GW Pharma (GWPH) PT Raised to $257 at Goldman Sachs on Epidiolex Revenue Blowout
Tweet Send to a Friend
Goldman Sachs analyst Salveen Richter raised the price target on GW Pharma (NASDAQ: GWPH) to $257.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
